Citation Impact
Citing Papers
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
No health without mental health
2007 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Mapping brain asymmetry
2003 Standout
MRI correlates of treatment response in first episode psychosis
1998
Role of glutamate in schizophrenia: integrating excitatory avenues of research
2008
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
1993
The neuropathology of schizophrenia
1999
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task
1998
Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
1999
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
2005
An integrated view of pathophysiological models of schizophrenia
1999
Glutamate uptake
2001 Standout
Preliminary Findings of Antistreptococcal Antibody Titers and Basal Ganglia Volumes in Tic, Obsessive-compulsive, and Attention-Deficit/Hyperactivity Disorders
2000
Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study
1999
Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings
2000
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
Schizophrenia and the α7 Nicotinic Acetylcholine Receptor
2007
Schizophrenia
2009 Standout
Childhood-Onset Schizophrenia
1997
Duration of untreated psychosis: a critical examination of the concept and its importance
2001
Vitamin E Treatment for Tardive Dyskinesia
1999
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Symptomatic and Functional Recovery From a First Episode of Schizophrenia or Schizoaffective Disorder
2004
Dopamine Specifically Inhibits Forebrain Neural Stem Cell Proliferation, Suggesting a Novel Effect of Antipsychotic Drugs
2005
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
2009
Decreased Caudate Volume in Neuroleptic-Naive Psychotic Patients
1998
MRI anatomy of schizophrenia
1999
The adolescent brain and age-related behavioral manifestations
2000 Standout
Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia
1995
Slow onset of CNS drugs: can changes in protein concentration account for the delay?
2001
Mapping of grey matter changes in schizophrenia1This work was presented, in part, at the VIth International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA, April 1997.1
1999
Prefrontal neurons and the genetics of schizophrenia
2001
Hippocampal Volume in First-Episode Psychoses and Chronic Schizophrenia
1999
An atlas of genetic correlations across human diseases and traits
2015 Standout
Novel antipsychotics and new onset diabetes
1998
Caudate, putamen, and globus pallidus volume in schizophrenia: A quantitative MRI study
1995
Neuroimaging and the Cognitive Neuroscience of Schizophrenia
1996
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
2006 Standout
Relationship of neuropsychological and MRI measures to age of onset of schizophreniaa
1998
Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity
1997
Brain Anatomic Magnetic Resonance Imaging in Childhood-Onset Schizophrenia
1996
Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence
2002
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis
1999
Prefrontal and Striatal Volumes in Monozygotic Twins Concordant and Discordant for Schizophrenia
2010
Structural brain imaging in schizophrenia: a selective review
1999
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
1997
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Endophenotypes in schizophrenia: A selective review
2009
Mapping cortical change across the human life span
2003 Standout
Schizophrenia: A disease of heteromodal association cortex?
1996
Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials
2001
Neurobiological findings in early phase schizophrenia
2000
Voxelwise Meta-Analysis of Gray Matter Abnormalities in Bipolar Disorder
2010
Dose Response and Dose Equivalence of Antipsychotics
2004
The Antiphospholipid Syndrome
2002 Standout
Stress and the brain: from adaptation to disease
2005 Standout
The magical number 4 in short-term memory: A reconsideration of mental storage capacity
2001 Standout
Rethinking schizophrenia
2010 StandoutNature
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
Neuropathology of Schizophrenia: Cortex, Thalamus, Basal Ganglia, and Neurotransmitter-specific Projection Systems
1997
Informing patients about tardive dyskinesia
1998
Focal Gray Matter Density Changes in Schizophrenia
2001
Investigation of frontal lobe subregions in first-episode schizophrenia1This study was presented in part at the 1996 Meeting of the Society for Research in Psychopathology in Atlanta, GA, and the 1997 Meeting of the International Congress on Schizophrenia Research in Colorado Springs, CO.1
1999
A Separate Disease Within the Syndrome of Schizophrenia
2001
Monitoring and Care of Young People at Incipient Risk of Psychosis
1996
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
A review of MRI findings in schizophrenia
2001 Standout
Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder
1999
Change in Basal Ganglia Volume Over 2 Years in Patients With Schizophrenia: Typical Versus Atypical Neuroleptics
1999
Hippocampal volume reduction in male schizophrenic patients
1998
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Pharmacogenetics of bipolar disorder
2002
Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder
2003
Mental health of young people: a global public-health challenge
2007 Standout
Subcortical MRI Volumes in Neuroleptic-Naive and Treated Patients With Schizophrenia
1998
Three-Dimensional Analysis With MRI and PET of the Size, Shape, and Function of the Thalamus in the Schizophrenia Spectrum
1999
Diabetes mellitus in schizophrenic patients
1996
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
2001
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
2000
Whole Brain Segmentation
2002 Standout
Impairment of early cortical processing in schizophrenia: An event-related potential confirmation study
1993
Voxel-Based Morphometry—The Methods
2000 Standout
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: A pilot magnetic resonance imaging study
1997
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Meta-Analysis of Regional Brain Volumes in Schizophrenia
2000
Lower Left Temporal Lobe MRI Volumes in Patients With First-Episode Schizophrenia Compared With Psychotic Patients With First-Episode Affective Disorder and Normal Subjects
1998
Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?
1998
MRI Study of Caudate Nucleus Volume and Its Cognitive Correlates in Neuroleptic-Naive Patients With Schizotypal Personality Disorder
2002
Recurrent miscarriage
2006 Standout
Brain abnormality in schizophrenia
1998
Brain Abnormalities in Early-Onset Schizophrenia Spectrum Disorder Observed With Statistical Parametric Mapping of Structural Magnetic Resonance Images
2000
STRUCTURAL BRAIN IMAGING IN SCHIZOPHRENIA
1998
Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network
1999
Thalamic and amygdala–hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis
1999
Impaired attention-dependent augmentation of MMN in nonparanoid vs paranoid schizophrenic patients: A comparison with obsessive-compulsive disorder and healthy subjects
1997
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
2002
Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review
2008
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Psychobiologic Correlates of Treatment Response in Schizophrenia
1996
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
A Follow-up Magnetic Resonance Imaging Study of Schizophrenia
1998
Absence of the Adhesio Interthalamica as a Marker of Early Developmental Neuropathology in Schizophrenia: An MRI and Postmortem Histologic Study
1998
Automatically Parcellating the Human Cerebral Cortex
2003 Standout
Pharmacogenetics and the serotonin system: initial studies and future directions
2000
An open label trial of C-1073 (mifepristone) for psychotic major depression*
2002
Functional Neuroimaging Studies of Depression: The Anatomy of Melancholia
1998
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
2003 StandoutScience
Absence of regional hemispheric volume asymmetries in first-episode schizophrenia
1994
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Risperidone versus typical antipsychotic medication for schizophrenia
2003
PET and MRI of the thalamus in never-medicated patients with schizophrenia
1996
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
1996 Standout
Temporal lobe morphology in childhood-onset schizophrenia [published erratum appears in Am J Psychiatry 1996 Jun;153(6):851]
1996
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine
1997
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers
2006
Time to clozapine response in a standardized trial
1997
Reduced Volume of Limbic System–Affiliated Basal Ganglia in Mood Disorders:
1999
Interventions for enhancing medication adherence
2014 Standout
Differential aging of the human striatum: longitudinal evidence.
2003
Atypical Antipsychotics: New Directions and New Challenges in the Treatment of Schizophrenia
2001
Vulnerability to psychopathology: A biosocial model.
1999
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
The Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry
2000 StandoutNobel
Idiosyncratic Drug Reactions: Current Understanding
2006
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of J.A. Lieberman being referenced
Quantitative characterization of eye tracking dysfunction in schizophrenia
2000
Prospective Study of Psychobiology in First-episode Schizophrenia at Hillside Hospital
1992
The Effects of Clozapine on Tardive Dyskinesia
1991
A Selective Review of Biological Markers in Schizophrenia
1991
HLA-B38, DR4, DQw3 and Clozapine-Induced Agranulocytosis in Jewish Patients With Schizophrenia
1990
Brain Morphology, Dopamine, and Eye-Tracking Abnormalities in First-Episode Schizophrenia
1993
Olanzapine versus haloperidol in the treatment of first episode psychosis
1998
Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia.
1990
Evidence for sensitization in the early stage of schizophrenia
1992
Mismatch negativity, neuropsychological deficits and psychopathology in chronic schizophrenia
1995
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol on treatment-resistant patients with schizophrenia and schizoaffective disorder
2001
Evidence for sensitization in the early stage of schizophrenia
1997
Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients
1995
Time to treatment response in successive episodes of early onset schizophrenia
1995
The Prevalence of Tardive Dyskinesia
1991
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
1994
Predictors of response to clozapine.
1994
Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome
1994
Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia
2003
Diabetes and development of tardive dyskinesia
1993
Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.
1992
Clozapine, negative symptoms, and extrapyramidal side effects.
1994